New Research on Cannabinoid Hyperemesis Syndrome (CHS) with Dr. Codi Peterson and Megan Mbengue
BIOACTIVEShow Notes
On this episode of the Bioactive Podcast, Dr. Riley Kirk is joined by Dr. Codi Peterson and Megan Mbengue to discuss their newly published paper on Cannabinoid Hyperemesis Syndrome (CHS). Drawing from their recently published research and clinical experience, they explore what CHS is, how it presents, and why it is often misunderstood or misdiagnosed. The conversation covers early warning signs, the prodromal phase, and the severe symptoms patients experience, including the challenges faced in emergency care settings. They also address common misconceptions around cannabis use patterns, frequency, and the role of THC in the development of CHS.
They discuss key factors influencing CHS, including consumption methods such as vaping versus flower, rapid THC absorption, tolerance, and the impact of high-potency products. The discussion explores myths around pesticides, synthetic cannabinoids, and the importance of distinguishing correlation from causation in cannabis-related health outcomes. Additionally, they examine strategies for reducing risk, including tolerance breaks, balanced use, and patient education without stigma. The dialogue further highlights the importance of compassionate care, proper diagnosis, and the role of healthcare professionals in bridging the gap between cannabis use and medical understanding. Finally, they touch on future research directions, the importance of data collection, and how education can shape safer, more informed cannabis use.
This is a conversation for anyone using cannabis regularly, healthcare professionals seeking to better understand CHS, or patients navigating unexplained symptoms. Whether you're exploring cannabis for wellness or working in clinical settings, this episode provides critical insight into responsible use, early warning signs, and the evolving science behind cannabis-related health outcomes.
Chapters
00:00 CHS Is Real
00:58 Welcome And Guests
01:43 Publishing The Study
03:47 What Is CHS
05:04 ER Reality Check
06:17 Scromiting And Severity
09:16 Survey Size And Reach
10:48 Vapes Versus Flower
11:42 Use Patterns And Myths
15:55 Prodrome Phase Warning
18:13 Triggers And Cutting Down
23:41 Is THC The Culprit
26:06 Why Vapes Hit Faster
27:56 Vaping And THC Spikes
29:22 Pesticides Myth Busting
31:57 Tolerance Breaks And Balance
34:08 CHS Education Not Stigma
36:45 ER Diagnosis And Overdiagnosis
38:55 Who Gets CHS Demographics
41:22 Early Warning Signs
43:28 Synthetic Cannabinoid Risks
45:37 Whole Plant Over Isolates
50:02 Future Papers And Next Steps
51:57 Compassion And Closing
Read the Research on CHS
Cannabinoid Hyperemesis Syndrome Publication:
Note: This publication is currently behind a paywall but will be available for free on Patreon.
Sponsor
Thank you to our sponsor Storz & Bickel! S&B makes medical-grade dry herb vaporizers which are some of my favorite products to use daily. If you want to check them out, head to storz-bickel.com and use code Riley10 for 10% off most items!
Want Exclusive Content and Ad-Free Episodes?
Join the Bioactive Patreon community for as little as $1/month to ask guests your burning questions, access exclusive content, and connect with Dr. Kirk one-on-one.
www.Patreon.com/Cannabichem
🔔 Don’t forget to like, subscribe, and hit the notification bell for more expert insights into cannabis science, pharmacology, and plant medicine.
Sign Up for Emails
www.AppliedPharmacognosy.org
Keep Up with Dr. Riley Kirk
https://www.bioactivepodcast.com/
https://www.youtube.com/@cannabichem
https://instagram.com/cannabichem
https://www.appliedpharmacognosy.org/ Learn more about your ad choices. Visit megaphone.fm/adchoices
More from BIOACTIVE
What are cannabis terpenes, how do they influence aroma and consumer experiences, and what do we know about their safety? On this episode of the Bioactive Podcast, Dr. Riley Kirk sits down with Dr. Shawna Vreeke, PhD, DABT, Head of Toxicology at True Terpenes, to explore the science of cannabis terpenes, terpene chemistry, cannabinoid interactions, and consumer safety. With a PhD in Chemistry focused on toxin formation in vape device aerosols and expertise in toxicology risk assessment, Shawna shares insights into what current research tells us about terpenes and where important questions remain unanswered.
Dr. Riley Kirk welcomes Dr. Miyabe Shields for a deep dive into cannabis real-world data, cannabis consumption patterns, dosing, neurodivergent cannabis use, and the Endocannabinoid System (ECS). As co-founders of the Network of Applied Pharmacognosy (NAP), Riley and Miyabe discuss the newly accessible Real Data Project, including what large-scale consumer data can reveal about how people actually use cannabis in their everyday lives.
What if carbon is one of the most overlooked inputs in plant nutrition? In this episode of the Bioactive Podcast, Dr. Riley Kirk sits down with Nik Nikolayev, CEO of Rooted Leaf Agritech, to explore the science of carbon-based fertilizers, plant nutrition, biostimulants, organic acids, and the chemistry behind plant growth, yield, and quality.
Dr. Riley Kirk has Dr. Denise Valenti on the podcast to discuss cannabis and driving, cannabis impairment, THC testing, and the challenges of determining whether someone is actually too impaired to drive. They explore why THC levels in the body do not necessarily correspond to impairment and how cannabis can affect vision, peripheral vision, contrast sensitivity, eye movement, balance, and pupil response.
In this episode of the Bioactive Podcast, Dr. Riley Kirk sits down with Dr. Rick Pescatore, board-certified emergency physician, Editor-in-Chief of Emergency Medicine News, and founder of BellyMD, for a fascinating deep dive into the gut-brain connection and what it means for cannabis users and patients dealing with unexplained digestive symptoms.